A Phase 2, Randomized Study of Bortezomib/Dexamethasone With or Without Elotuzumab in Subjects With Relapsed/Refractory Multiple Myeloma
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Progression-free survival (PFS) - Time from randomization to date of first tumor progression or death due to any cause
Every 21 +/-7 days (Cycles 1-8) relative to the first dose of study medication
No
Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb
United States: Food and Drug Administration
CA204-009
NCT01478048
January 2012
April 2015
Name | Location |
---|---|
Washington University School of Medicine | Saint Louis, Missouri 63110 |
Carle Cancer Center | Urbana, Illinois 61801 |
Palm Beach Cancer Institute | West Palm Beach, Florida 33401 |
Greater Baltimore Medical Center | Baltimore, Maryland 21204 |
Integrated Community Oncology Network | Jacksonville Beach, Florida 32250 |
Medical Oncology Care Associates | Orange, California 92668 |
University of Chicago Medical Center | Chicago, Illinois 60637 |
Local Institution | Chicago, Illinois |
Local Institution | Baltimore, Maryland |
Local Institution | Bronx, New York |
Local Institution | Portland, Oregon |
Local Institution | Vancouver, Washington |
Local Institution | Green Bay, Wisconsin |
Oncology Specialists, S.C. | Park Ridge, Illinois 60068 |
Local Institution | Corona, California |
Local Institution | Hamden, Connecticut |
Local Institution | Fort Lauderdale, Florida |
Local Institution | Wichita, Kansas |
Local Institution | Springfield, Massachusetts |
Local Institution | Duluth, Minnesota |
Local Institution | Wilmington, North Carolina |
Local Institution | Duncansville, Pennsylvania |
Local Institution | North Charleston, South Carolina |
Local Institution | Austin, Texas |
Local Institution | Arlington, Virginia |
Local Institution | New Orleans, Louisiana |
Kentucky Cancer Clinic | Pikeville, Kentucky 41501 |
Sharp Clinical Oncology Research | San Diego, California 92123 |
Compassionate Cancer Care Medical Group, Inc | Fountain Valley, California 92708 |
Local Institution | Chattanooga, Tennessee |
Local Institution | Little Rock, Arkansas |
Local Institution | Iowa City, Iowa |
Local Institution | Louisville, Kentucky |
Local Institution | Detroit, Michigan |
Local Institution | Honolulu, Hawaii |
Local Institution | Las Vegas, Nevada |
Investigative Clinical Research of Indiana, LLC | Indianapolis, Indiana 46254 |
Cancer Care Specialists of Central Illinois | Decatur, Illinois 62256 |
Northwest Cancer Center | Houston, Texas 77042 |
UCLA Department of Medicine | Los Angeles, California 90005 |
Mercy Medical Research Institute | Springfield, Missouri 65807 |
Cancer Center Of Acadiana | Lafayette, Louisiana 70503 |
Reliant Medical Group, Inc | Worcester, Massachusetts 01608 |